$1.85 (-1.34%)

Volume: 24.275k

Closed: Dec 02, 2022

Hollow Logo Score: -0.741

Cellectar Biosciences Stock Forecast

$1.85 (-1.34%)

Volume: 24.275k

Closed: Dec 02, 2022

Score Hollow Logo -0.741

Cellectar Biosciences Stock Price (Quote) NASDAQ:CLRB

$1.85 ( -1.34% ) Friday, 2nd Dec 2022

Range Low Price High Price Comment
30 days $1.77 $2.09 Friday, 2nd Dec 2022 CLRB stock ended at $1.85. This is 1.34% less than the trading day before Thursday, 1st Dec 2022. During the day the stock fluctuated 4.47% from a day low at $1.79 to a day high of $1.87.
90 days $1.75 $5.31
52 weeks $0.337 $6.76

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
2022-12-02 $1.80 $1.87 $1.79 $1.85 24 275
2022-12-01 $1.97 $1.97 $1.82 $1.87 24 780
2022-11-30 $1.81 $1.89 $1.79 $1.85 51 653
2022-11-29 $1.97 $1.97 $1.82 $1.88 44 234
2022-11-28 $1.85 $1.98 $1.85 $1.89 16 957
2022-11-25 $1.82 $1.98 $1.80 $1.92 21 390
2022-11-23 $1.94 $1.94 $1.77 $1.91 29 223
2022-11-22 $1.90 $1.90 $1.80 $1.87 35 056
2022-11-21 $1.99 $2.02 $1.88 $1.90 22 607
2022-11-18 $1.92 $2.02 $1.86 $1.94 16 930
2022-11-17 $1.86 $1.98 $1.86 $1.87 47 111
2022-11-16 $1.99 $1.99 $1.87 $1.90 22 473
2022-11-15 $1.90 $1.99 $1.88 $1.89 26 581
2022-11-14 $1.90 $2.04 $1.89 $1.93 25 809
2022-11-11 $1.89 $1.99 $1.88 $1.89 26 353
2022-11-10 $1.87 $2.00 $1.86 $1.90 41 037
2022-11-09 $1.91 $1.98 $1.85 $1.89 27 754
2022-11-08 $1.90 $1.98 $1.86 $1.93 27 730
2022-11-07 $1.86 $1.95 $1.81 $1.86 30 534
2022-11-04 $1.98 $2.01 $1.85 $1.89 19 193
2022-11-03 $1.97 $2.02 $1.90 $1.90 27 222
2022-11-02 $2.05 $2.09 $1.92 $2.04 19 596
2022-11-01 $2.12 $2.24 $1.96 $2.02 46 865
2022-10-31 $2.17 $2.25 $2.00 $2.02 35 468
2022-10-28 $1.98 $2.15 $1.98 $2.10 23 193
2022-10-27 $1.98 $2.10 $1.98 $2.02 39 096
2022-10-26 $2.08 $2.15 $1.98 $2.00 50 530
2022-10-25 $2.00 $2.20 $2.00 $2.11 77 805
2022-10-24 $1.88 $2.07 $1.83 $2.04 99 770
2022-10-21 $1.86 $1.88 $1.75 $1.82 326 862
2022-10-20 $2.00 $2.11 $1.86 $1.96 73 696
2022-10-19 $2.06 $2.31 $2.02 $2.02 73 432
2022-10-18 $2.11 $2.19 $1.92 $2.06 107 834
2022-10-17 $2.08 $2.15 $1.95 $2.12 211 965
2022-10-14 $2.16 $2.25 $2.09 $2.09 29 108
2022-10-13 $2.38 $2.38 $2.18 $2.22 77 228
2022-10-12 $2.76 $2.76 $2.41 $2.47 62 989
2022-10-11 $3.00 $3.00 $2.74 $2.81 61 050
2022-10-10 $3.29 $3.43 $2.93 $2.93 61 230
2022-10-07 $3.66 $3.70 $3.33 $3.35 21 801
2022-10-06 $3.48 $3.50 $3.46 $3.46 1 165
2022-10-05 $3.39 $3.42 $3.35 $3.42 8 256
2022-10-04 $3.70 $3.70 $3.32 $3.40 22 984
2022-10-03 $3.33 $3.43 $3.33 $3.36 22 829
2022-09-30 $3.43 $3.65 $3.36 $3.36 5 113
2022-09-29 $4.02 $4.02 $3.35 $3.36 24 965
2022-09-28 $3.66 $4.12 $3.62 $3.64 18 952
2022-09-27 $3.50 $3.68 $3.41 $3.68 14 079
2022-09-26 $3.82 $3.82 $3.43 $3.51 24 678
2022-09-23 $3.95 $3.95 $3.62 $3.75 23 338

Hot Stocks To Watch:

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT